The Effect of Neurofeedback and Cranial Electrotherapy on Immune Function Within a Group of HIV+ Subjects: A Controlled Study

Abstract

This study investigated the effects of neurofeedback and cranial electrotherapy on a group of subjects (n = 40) with the human immunodeficiency virus (HIV) over a 16-week period. Subjects were randomly assigned to one of four groups: neurofeedback only (n = 10), cranial electrotherapy only (n = 10), combined neurofeedback and cranial electrotherapy (n = 10), and a waitlist control group (n = 10). After 16-weeks, CD4 counts were significantly greater than controls for the neurofeedback group and combined group. There was no significant change in CD4 count for the cranial electrotherapy group. Results of this pilot study suggest that neurofeedback may improve immune function and warrants further investigation.